Evolution of the gut Amicrobiome during the pathogenesis of smoking-associated Kras-mutant lung cancer

被引：0

作者：

Treekitkarnmongkol, Warapen ^{[1
]}

Finnicum, Casey ^{[2
]}

Sinjab, Ansam ^{[1
]}

Hassane, Maya ^{[3
]}

Davis, Christel ^{[2
]}

Davies, Gareth E. ^{[2
]}

Hoffman, Kristi L. ^{[4
]}

Fujimoto, Junya ^{[1
]}

McAllister, Florencia ^{[1
]}

Sepesi, Boris ^{[1
]}

Cascone, Tina ^{[1
]}

Jenq, Robert R. ^{[1
]}

Petrosino, Joseph ^{[4
]}

Ehli, Erik ^{[2
]}

Moghaddam, Seyed J. ^{[1
]}

Kadara, Humam ^{[1
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

[2] Avera Inst Human Genet, Sioux Falls, SD USA

[3] Amer Univ Beirut, Beirut, Lebanon

[4] Baylor Coll Med, Houston, TX 77030 USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-3349

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3349

引用

页数：2

共 50 条

[31] Network analysis of differentially expressed smoking-associated mRNAs, lncRNAs and miRNAs reveals key regulators in smoking-associated lung cancer
Chen, Ying
Pan, Youmin
Ji, Yongling
Sheng, Liming
Du, Xianghui
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4991 - 5002
[32] In vivo CRISPR screening identifies mediators of immune evasion in KRAS-mutant lung cancer
Boumelha, Jesse
Romero-Clavijo, Pablo
de Carne, Sophie
Molina-Arcas, Miriam
Downward, Julian
CANCER RESEARCH, 2022, 82 (12)
[33] Combination Immunotherapy with MEK Inhibitor for Treatment of Kras-Mutant Lung Cancer in Animal Model
Lee, Jong Woo
Zhang, Yu
Choi, Justin
Sharma, Roshan
Park, Hee Sun
Kaftan, Edward
Papadimitrakopoulou, Vassiliki
Herbst, Roy
Koo, J. Peter
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1319 - S1319
[34] Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer.
Arbour, Kathryn Cecilia
Ricciuti, Biagio
Rizvi, Hira
Hellmann, Matthew D.
Yu, Helena Alexandra
Ladanyi, Marc
Kris, Mark G.
Arcila, Maria E.
Rudin, Charles M.
Lito, Piro
Awad, Mark M.
Riely, Gregory J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[35] RELATIONSHIP OF PASSIVE SMOKING TO RISK OF LUNG-CANCER AND OTHER SMOKING-ASSOCIATED DISEASES
LEE, PN
CHAMBERLAIN, J
ALDERSON, MR
BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 97 - 105
[36] Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
El Osta, Badi
Behera, Madhusmita
Kim, Sungjin
Berry, Lynne D.
Sica, Gabriel
Pillai, Rathi N.
Owonikoko, Taofeek K.
Kris, Mark G.
Johnson, Bruce E.
Kwiatkowski, David J.
Sholl, Lynette M.
Aisner, Dara L.
Bunn, Paul A.
Khuri, Fadlo R.
Ramalingam, Suresh S.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 876 - 889
[37] Smoking-associated DNA methylation markers predict lung cancer incidence
Yan Zhang
Magdeldin Elgizouli
Ben Schöttker
Bernd Holleczek
Alexandra Nieters
Hermann Brenner
Clinical Epigenetics, 2016, 8
[38] Smoking-associated DNA methylation markers predict lung cancer incidence
Zhang, Yan
Elgizouli, Magdeldin
Schoettker, Ben
Holleczek, Bernd
Nieters, Alexandra
Brenner, Hermann
CLINICAL EPIGENETICS, 2016, 8
[39] Impact of Neuro-Psychological Factors on Smoking-Associated Lung Cancer
Schuller, Hildegard M.
CANCERS, 2014, 6 (01): : 580 - 594
[40] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
Jacqueline V. Aredo
Sukhmani K. Padda
Current Treatment Options in Oncology, 2018, 19

← 1 2 3 4 5 →